Consequently, HSP60-derived APLs hold promise as a treatment option for various autoimmune diseases such as RA, diabetes, and atherosclerosis, as well as infections including SARS-CoV-2 and other inflammatory conditions [109]. This evidence concerns the gene HSPD1 and autoimmune disease.